Roche is a world leader in biotechnology, cancer medicines and diagnostics. The Roche Group employs around 80,000 people worldwide, and markets its medicinal products in more than 150 countries.

Latest Roche news

  1. Hospital networks: quo vadis?

    Date: 22/05/2017
    Hospitals are increasingly joining forces in networks of different types, sometimes with other healthcare players. This is an unmistakable trend, but forming networks is also an important strategic decision. How can hospitals ensure the right decisions are taken, both today and tomorrow, guaranteeing a robust, resilient and versatile organisation in the long run? Changes are rapidly succeeding one another, but who knows what healthcare will be like fifteen years from now and what the best set-up would be for these networks? No one can predict the future. However, despite all the uncertainties, a scenario analysis can help in the decision-making process.
    Read More
  2. Innovative cancer treatments: how much are we willing to pay?

    Date: 14/09/2016
    One man in three and one woman in four will develop cancer before their 75th birthday. In Belgium, cancer is the second major cause of disease burden after cardiovascular diseases and it is unlikely this will change in the foreseeable future. Increasingly better but more expensive cancer therapies are becoming available. Needless to say, in these times of austerity, the public budget for cancer treatment is under pressure. How can we ensure all patients continue to have access to these expensive but potentially life-saving medicines at a price society can afford, while at the same time encouraging pharmaceutical companies to innovate?
    Read More
  3. The need for a uniform database for real-world evidence and data

    Date: 23/06/2016
    Ever heard of ‘real-world evidence & data’? The healthcare sector is attaching more and more importance to this kind of information on medication use. Particularly in the field of oncology, where quite a few innovative medicines are brought to the market at a fast pace. The search for a uniform, easy and standardised way to collect relevant real-world data is a challenge. Together with our Chair Partner Roche, we are happy to put our shoulders to the wheel within the research field of the Vlerick Healthcare Management Centre.
    Read More
  4. A matter of life and death

    Date: 17/03/2015
    There is clearly mutual respect – and a good deal of excitement – at the launch of the new Roche Chair “Driving patient access to innovative medicines”. After all, it’s not every day that we get the chance to work on matters relating to life and death, but that is absolutely the case in this new partnership with Roche, the multinational pharmaceutical company with headquarters in Switzerland. Richard Erwin, Managing Director at Roche Belgium since 2013, explains the attraction.
    Read More
All Partners news

& Rankings

Equis Association of MBAs AACSB Financial Times